Science News

That 'Four Hour Erection': Discovery May Help Prevent Complication Of Priapism

ScienceDaily (Oct. 26, 2009) — For men coping with painful erections lasting for long periods of time, or priapism, new research published online in The FASEB Journal offers hope.

That's because researchers from the United States and China show that the enzyme adenosine deaminase may prevent priapism from progressing to penile fibrosis, a condition associated with the build up of scar tissue and eventual impotence. As penile fibrosis is a complication of priapism, so priapism is a complication of sickle cell disease. Adenosine deaminase, which breaks down adenosine, is already used in humans as a treatment for a rare immune disorder.

"Coping with priapism is hard enough, but knowing that it can ultimately lead to fibrosis within the penis adds insult to injury," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "Hopefully this discovery can yield new drugs that relieve the excitatory signals sent by adenosine so that these men to get some relief."

For the study, the researchers used two priapism animal models to determine the role of increased adenosine in penile fibrosis, a dangerous problem believed to be caused by priapism. One model was that of adenosine deaminase-deficient mice and the other was sickle cell disease transgenic mice. Both of these sets of mutant mice were treated with the enzyme adenosine deaminase enzymes to lower adenosine levels. After 8 weeks, they found that this enzyme significantly lowered adenosine levels in the penises of both groups of test mice. Reduction of adenosine by these enzymes successfully prevented and corrected penile fibrosis in both sets of mice.

"Because of our study, we have revealed that increased adenosine signaling contributes to the pathogenesis of the progression of priapism to penile fibrosis," said Yang Xia, a scientist involved in the study from the University of Texas-Houston Medical School's Department of Biochemistry and Molecular Biology. "This finding led to a novel therapeutic possibility to treat and prevent this dangerous complication seen in priapic humans by targeting on this signaling pathway in the near future."

Recommend this story on Facebook, Twitter,
and Google +1:

Other bookmarking and sharing tools:

| More

Story Source:

The above story is reprinted from materials provided by Federation of American Societies for Experimental Biology, via EurekAlert!, a service of AAAS.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. Jiaming Wen, Xianzhen Jiang, Yingbo Dai, Yujin Zhang, Yuxin Tang, Hong Sun, Tiejuan Mi, Prasad V. Phatarpekar, Rodney E. Kellems, Michael R. Blackburn, and Yang Xia. Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling. FASEB Journal, 2009; DOI: 10.1096/fj.09-144147
APA

MLA

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Search ScienceDaily

Number of stories in archives: 113,981

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.

 
  more breaking science news

Social Networks


Recommend this story on Facebook, Twitter,
and Google +1:
Other bookmarking and sharing tools:
| More

Breaking News

... from NewsDaily.com

In Other News ...

Copyright Reuters 2008. See Restrictions.

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

 
Post this page to your favorite social bookmarking site:
close
Include this item in your blog or web site:
close
Cite this article in your essay, paper, or report:
close
Email this page's link to a friend or colleague:
close